A patient with a history of hypertension and coronary artery disease presents with crackles in the lower lung fields, peripheral edema, and orthopnea. After administering diuretics and oxygen therapy, what would be the most important next step for the nurse to monitor in this patient?

A) Monitor serum potassium levels

B) Assess for jugular venous distention

C) Check for improvement in peripheral edema

D) Evaluate changes in blood pressure

A patient with a history of hypertension and coronary artery disease is experiencing worsening heart failure, evidenced by crackles in the lung bases, orthopnea, and peripheral edema. After the administration of diuretics, which assessment finding would indicate that the treatment is effective?

B) Clear lung sounds on auscultation

A) Increased blood pressure and reduced heart rate

B) Clear lung sounds on auscultation

C) Elevated B-type natriuretic peptide (BNP) levels

A patient with congestive heart failure is experiencing persistent respiratory distress despite treatment with diuretics and supplemental oxygen. The patient also shows signs of fluid retention, anxiety, and electrolyte imbalances. Which of the following should be the priority nursing intervention to address the patient's worsening condition?

D) Initiate a continuous positive airway pressure (CPAP) therapy to improve oxygenation.

A) Increase the dose of the current diuretic to enhance fluid removal.

B) Administer potassium supplements to correct hypokalemia immediately.

C) Prepare the patient for an echocardiogram to evaluate cardiac function.

D) Initiate a continuous positive airway pressure (CPAP) therapy to improve oxygenation.

A patient with heart failure is showing signs of worsening respiratory distress, peripheral edema, and electrolyte imbalance despite ongoing treatment. Which intervention should the nurse prioritize to address the current clinical status of the patient?

D) Initiate oxygen therapy using a non-rebreather mask to improve oxygenation.

A) Increase the dose of diuretics to reduce fluid overload.

B) Administer potassium supplements to address hypokalemia.

C) Arrange for an echocardiogram to assess cardiac function.

D) Initiate oxygen therapy using a non-rebreather mask to improve oxygenation.

A patient with heart failure and renal impairment is experiencing worsening symptoms despite current treatment. Which of the following interventions should the nurse anticipate as most beneficial in addressing fluid overload while minimizing further renal damage?

B) Initiate an aldosterone antagonist.

A) Increase the dose of loop diuretics.

B) Initiate an aldosterone antagonist.

C) Restrict fluid intake to 1 liter per day.

D) Administer intravenous fluids to improve renal perfusion.

A patient with systolic dysfunction and signs of right-sided heart failure is being treated with diuretics, ACE inhibitors, and potassium supplements. Despite these interventions, the patient's BNP levels have increased, and renal function has declined. Considering the current findings, what is the most appropriate next step in the management of this patient to address fluid overload and renal function?

B) Initiate an aldosterone antagonist

A) Increase the dose of diuretics

B) Initiate an aldosterone antagonist

A patient with heart failure is experiencing a rise in creatinine levels and mild hyperglycemia while on ACE inhibitors and diuretics. Which nursing intervention is the most appropriate to address these concerns?

C) Collaborate with the healthcare provider to adjust diuretic therapy to reduce renal strain.

A) Increase the dosage of the ACE inhibitor to enhance renal protection.

B) Suggest the addition of a calcium channel blocker to manage blood pressure.

C) Collaborate with the healthcare provider to adjust diuretic therapy to reduce renal strain.

D) Initiate a high-protein diet to support renal function and manage glucose levels.

A patient with heart failure and significant coronary artery disease is being evaluated for percutaneous coronary intervention (PCI). The patient's renal function is compromised with a creatinine level of 2.2 mg/dL, and they exhibit mild hyperglycemia. Which nursing intervention is most important to prioritize before the procedure?

C) Ensure the patient's renal function is closely monitored and consult nephrology.

A) Educate the patient about the benefits and risks of PCI.

B) Administer a diuretic to manage fluid retention prior to the procedure.

C) Ensure the patient's renal function is closely monitored and consult nephrology.

D) Encourage the patient to drink plenty of fluids to prevent dehydration.

A patient with a complex medical history presents with increasing dyspnea on exertion, chest discomfort, and slightly elevated troponin levels indicating mild cardiac injury. Their current management plan includes beta-blockers and consideration for a calcium channel blocker. The patient also has elevated creatinine levels. Which of the following nursing interventions is most appropriate to address the patient's current condition while minimizing further renal impairment?

D) Collaborate with the nephrology team to adjust current medications and prioritize renal function monitoring.

A) Increase the dose of beta-blockers to further reduce myocardial oxygen demand and closely monitor blood pressure.

B) Initiate a low-dose diuretic to manage hypertension and monitor renal function closely.

C) Hold the beta-blocker and start an ACE inhibitor to manage both cardiac workload and renal protection.

D) Collaborate with the nephrology team to adjust current medications and prioritize renal function monitoring.

Cardiac - Nursing Case Study

Pathophysiology

• Primary mechanism: Coronary artery disease (CAD) leads to atherosclerosis, where plaque buildup narrows coronary arteries, reducing blood flow and oxygen supply to the heart muscle, potentially causing angina or myocardial infarction.

• Secondary mechanism: Heart failure results from the heart's inability to pump blood effectively, often due to weakened or stiffened heart muscles from previous myocardial infarctions or chronic hypertension, leading to fluid buildup and organ congestion.

• Key complication: Arrhythmias can arise due to disrupted electrical impulses in the heart, often exacerbated by myocardial damage or ischemia, increasing the risk of stroke or sudden cardiac death.

Patient Profile

Demographics:

58-year-old male, retired firefighter

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and shortness of breath

• Key symptoms: Fatigue, dizziness, palpitations, intermittent leg swelling

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 98.6°F, oxygen saturation 93% on room air

Section 1

As the nursing team continues their assessment, the patient's condition reveals additional concerning findings. On auscultation, there are audible crackles in the lower lung fields bilaterally, indicating potential pulmonary congestion. The patient reports increased shortness of breath while lying flat, a condition known as orthopnea, which is commonly associated with heart failure. Peripheral edema is observed, with noticeable swelling in the ankles and feet. Given the patient's history of hypertension and CAD, these findings suggest a worsening of heart failure, likely due to increased cardiac workload and fluid retention.

In response to these assessment findings, the healthcare team orders a series of diagnostic tests to further evaluate cardiac function and rule out acute coronary syndrome. An electrocardiogram (ECG) reveals sinus tachycardia with occasional premature ventricular contractions (PVCs), suggesting electrical instability. Laboratory results show elevated B-type natriuretic peptide (BNP) levels, confirming heart failure exacerbation. Creatinine levels are slightly elevated, indicating potential renal involvement, likely due to decreased perfusion secondary to compromised cardiac output.

The team initiates interventions to manage the patient's symptoms and prevent further deterioration. Diuretics are administered to alleviate fluid overload and reduce pulmonary congestion. Oxygen therapy is started to improve oxygen saturation and relieve dyspnea. The patient is closely monitored for changes in vital signs and response to treatment. These interventions aim to stabilize the patient, prevent acute complications, and prepare for further therapeutic strategies, such as potential cardiac catheterization to assess coronary artery patency and guide future management.

Section 2

As the patient continues to receive treatment, the healthcare team observes a change in the patient's status that prompts further evaluation. Despite the administration of diuretics and oxygen therapy, the patient's respiratory status shows minimal improvement. The patient remains tachypneic, with a respiratory rate persistently at 28 breaths per minute, and reports persistent orthopnea. Oxygen saturation levels are fluctuating between 88-90% on supplemental oxygen, indicating ongoing respiratory distress. Additionally, the patient exhibits increasing anxiety and restlessness, which could be attributed to impaired gas exchange and hypoxia.

The nursing team notes that the peripheral edema has not significantly decreased, and there is now mild ascites, suggesting continued fluid retention and possible right-sided heart failure involvement. The blood pressure is moderately elevated at 150/95 mmHg, and heart rate remains elevated at 110 beats per minute. Laboratory results are re-evaluated, revealing a further increase in BNP levels and a mild increase in creatinine, indicating worsening renal function. Electrolyte imbalances are also noted, with a drop in potassium levels to 3.2 mEq/L, likely due to diuretic therapy, necessitating correction to prevent further cardiac complications.

In response to these developments, the healthcare team revisits the patient's treatment plan. Adjustments to diuretic therapy are considered, alongside the introduction of potassium supplements to address hypokalemia. The team evaluates the need for advanced imaging, such as an echocardiogram, to assess cardiac function and guide potential adjustments in medication, such as the introduction of ACE inhibitors to reduce cardiac workload. Furthermore, the consideration of cardiac catheterization gains urgency to explore coronary artery patency, given the potential for ischemic contributions to the decompensation. Through careful clinical reasoning, the team aims to stabilize the patient further and prevent progression to more severe complications.

Section 3

As the healthcare team implements adjustments to the treatment plan, including altering diuretic therapy and administering potassium supplements, the patient undergoes further diagnostic evaluation to identify underlying causes of the persistent symptoms. An echocardiogram is performed and reveals moderately reduced left ventricular ejection fraction at 40%, indicating systolic dysfunction. Additionally, signs of right ventricular enlargement are observed, corroborating the suspicion of right-sided heart failure involvement. These findings prompt the team to initiate an ACE inhibitor to alleviate cardiac workload and improve cardiac output.

Despite these interventions, the patient's condition shows subtle signs of deterioration. The patient now exhibits episodes of paroxysmal nocturnal dyspnea, requiring frequent adjustments to oxygen therapy levels. Repeat laboratory tests indicate a further elevation in BNP to 1200 pg/mL, confirming worsening heart failure, while creatinine levels rise to 2.0 mg/dL, signaling progressive renal impairment. The patient's potassium levels have stabilized with supplementation, now reading 3.8 mEq/L, but new concerns arise with the detection of mild hyperglycemia, with blood glucose levels consistently around 145 mg/dL.

The healthcare team recognizes the need for rapid reassessment of the therapeutic approach. Consideration is given to the initiation of an aldosterone antagonist to address fluid overload and minimize further renal damage. Additionally, a decision is made to expedite cardiac catheterization to evaluate coronary artery patency and address potential ischemic contributions. The evolving clinical picture emphasizes the importance of dynamic, integrated management to stabilize the patient and prevent progression to more severe heart failure complications. The team remains vigilant, poised to reassess and recalibrate the treatment strategy based on the patient's responses and ongoing diagnostic insights.

Section 4

As the healthcare team continues to monitor the patient's progress, new diagnostic results shed light on the evolving situation. Cardiac catheterization reveals significant coronary artery disease, with a 70% stenosis in the left anterior descending artery and moderate diffuse disease in other vessels. These findings confirm ischemic contributions to the patient's heart failure, necessitating further intervention. The cardiology team discusses the potential benefits of percutaneous coronary intervention (PCI) to improve coronary blood flow and reduce the cardiac workload. Meanwhile, the initiation of the aldosterone antagonist begins to show promise, with a slight reduction in peripheral edema and a stabilization of the patient's weight, indicating a decrease in fluid retention.

Despite these positive developments, additional challenges arise. The patient's renal function continues to be a concern, with creatinine levels inching up to 2.2 mg/dL, reflecting ongoing renal strain likely exacerbated by both the heart failure and diuretic therapy. The mild hyperglycemia persists, suggesting a possible stress-induced hyperglycemic state or an emerging glucose metabolism disorder, necessitating consultation with an endocrinologist for further evaluation and management. The patient's blood pressure remains mildly elevated at 150/90 mmHg, despite the introduction of the ACE inhibitor, prompting consideration of additional antihypertensive agents to achieve optimal control.

The healthcare team remains vigilant, carefully balancing the need to address coronary artery disease while managing the delicate interplay of heart failure, renal function, and glucose control. The plan includes continuous monitoring and adjustment of medications, with the aim of stabilizing the patient's condition and preventing further complications. As these complexities unfold, the team prepares to engage in comprehensive discussions with the patient and their family, emphasizing the importance of adherence to the evolving treatment plan and lifestyle modifications essential for long-term management.

Section 5

As the healthcare team carefully navigates the management of the patient's complex condition, new complications emerge that require immediate attention. During a routine assessment, the patient reports increasing episodes of dyspnea on exertion and occasional chest discomfort, which raise concerns about myocardial oxygen supply and demand. The patient's vital signs reveal a heart rate of 96 bpm, blood pressure at 158/92 mmHg, and oxygen saturation at 91% on room air. These findings suggest that the balance between the patient's cardiac workload and oxygenation is becoming more tenuous.

A follow-up electrocardiogram (ECG) shows nonspecific ST-segment changes, prompting the team to order a troponin level to evaluate for possible cardiac ischemia. The troponin results return slightly elevated at 0.12 ng/mL, indicating a mild cardiac injury. This necessitates urgent review by the cardiology team to reassess the timing and urgency of the proposed percutaneous coronary intervention (PCI). In the meantime, adjustments to the patient's medical management are considered, including optimizing doses of beta-blockers to reduce myocardial oxygen demand and potentially introducing a calcium channel blocker to address the persistent hypertension.

Amid these developments, the patient's renal function is further scrutinized. The latest lab results show a creatinine level of 2.4 mg/dL, raising concerns about acute kidney injury due to the ongoing renal strain. The healthcare team deliberates on the need to adjust diuretic therapy to prevent further renal compromise while maintaining adequate fluid management. The challenge is to carefully titrate medications to ensure that all aspects of the patient's condition—cardiac, renal, and metabolic—are addressed cohesively. This requires close coordination among the cardiology, nephrology, and endocrinology teams, as well as active involvement of the patient and family in decision-making, to ensure adherence to the complex treatment regimen and to mitigate the risk of additional complications.